Literature DB >> 19783053

Nickel-quinolones interaction. Part 1 - Nickel(II) complexes with the antibacterial drug sparfloxacin: structure and biological properties.

Kalliopi C Skyrianou1, Eleni K Efthimiadou, Vassilis Psycharis, Aris Terzis, Dimitris P Kessissoglou, George Psomas.   

Abstract

The mononuclear nickel(II) complexes with the third-generation quinolone antibacterial agent sparfloxacin in the absence or presence of nitrogen donor heterocyclic ligands (1,10-phenanthroline or 2,2'-bipyridine) have been synthesized and characterized. The experimental data suggest that sparfloxacin acts as deprotonated bidentate ligand coordinated to Ni(II) ion through the ketone and carboxylato oxygens. The crystal structure of (1,10-phenanthroline)bis(sparfloxacinato) nickel(II), 2 has been determined by X-ray crystallography. The cyclic voltammograms of the complexes recorded in dmso solution and in 1/2 dmso/buffer (containing 150 mM NaCl and 15 mM trisodium citrate at pH 7.0) solution have shown that in the presence of CT DNA they can bind to CT DNA by the intercalative binding mode. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and 2 exhibits the highest binding constant to CT DNA. Competitive study with ethidium bromide (EB) has shown that the complexes can displace the DNA-bound EB indicating that they bind to DNA in strong competition with EB for the intercalative binding site. The antimicrobial activity of the complexes has been tested on three different microorganisms and has revealed that the inhibition provided by the complexes is slightly decreased in comparison to free sparfloxacin. The complexes exhibit good binding propensity to human and bovine serum albumin proteins having relatively high binding constant values.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783053     DOI: 10.1016/j.jinorgbio.2009.08.011

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  A β-carboline derivative-based nickel(ii) complex as a potential antitumor agent: synthesis, characterization, and cytotoxicity.

Authors:  Jing-Mei Yang; Yan-Hong Zhu; Sheng Chen; Xing Lu; Yi-Ming Wu; Feng-E Ma; Liang-Ping Li; Yang Yang; Zhen-Hao Shi; Kun-Yuan Huang; Xue Hong; Ping Jiang; Yan Peng
Journal:  Medchemcomm       Date:  2017-11-24       Impact factor: 3.597

2.  In Vitro Anticancer Activity of Novel Co(II) and Ni(II) Complexes of Non-steroidal Anti-inflammatory Drug Niflumic Acid Against Human Breast Adenocarcinoma MCF-7 Cells.

Authors:  Sema Caglar; Ahmet Altay; Mehmet Kuzucu; Bulent Caglar
Journal:  Cell Biochem Biophys       Date:  2021-04-29       Impact factor: 2.194

3.  Synthesis and characterization of the ligand based on benzimidazole and its copper complex: DNA binding and antioxidant activity.

Authors:  Huilu Wu; Fan Kou; Fei Jia; Bin Liu; Jingkun Yuan; Ying Bai
Journal:  Bioinorg Chem Appl       Date:  2011-11-21       Impact factor: 7.778

4.  Synthesis, Characterization, and Antifungal Studies of Cr(III) Complex of Norfloxacin and Bipiridyl Ligand.

Authors:  Anamika Debnath; Firasat Hussain; Dhanraj T Masram
Journal:  Bioinorg Chem Appl       Date:  2014-09-03       Impact factor: 7.778

5.  Synthesis, Structure, DNA Interaction, and SOD Activity of Three Nickel(II) Complexes Containing L-Phenylalanine Schiff Base and 1,10-Phenanthroline.

Authors:  Peiran Zhao; Shanshan Zhai; Jianfang Dong; Lei Gao; Xinru Liu; Lei Wang; Jinming Kong; Lianzhi Li
Journal:  Bioinorg Chem Appl       Date:  2018-07-05       Impact factor: 7.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.